Click to Share
 
 
  1. Latest News
  2. Submit Press Release
  1. PR Home
  2. Latest News
  3. Feeds
  4. Alerts
  5. Submit Free Press Release
  6. Journalist Account
  7. PRNewswire Distribution
Filter News
Show All Results
News By Country
News By Tag
Vaccine Remove
Related Tags


December 2014
Mo Su Sa Fr Th We Tu
22 21 20 19 18 17 16

vaccine Press Releases

  + XML/RSS  



By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Posts 1st Half 2012 Results Highlights include IRBP Granted U.S. Patent 8,053,197 for Auto-Immune Diseases & Plans for a Phase 2B NeuroVax Study and a Phase 3 RAVAX Study for RA.

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. On the Move Plans Listing on German Exchanges to Fund Blockbuster MS Drug NeuroVax & Pipeline

By Bharatbook
Bharatbook.com introduces a report " 2012 Deep Research Report on China Influenza Vaccine Industry " the report also introduced 8Million Pieces/year Influenza Vaccine project Feasibility analysis.

By Immune Response BioPharma, Inc.
Immune Response BioPharma, Inc. Terminates Blockbuster MS Drug NeuroVax Partnership Discusions With GSK

By enRight PR
“Vaccines play a crucial role in the eradication of diseases that affect millions of lives worldwide. The GCE Grant will help us accelerate the pace of research programs .” Dr. Krishna Ella, Co-Founder of Ella Foundation said.

By Cambridge Healthtech Institute
A Two Day Event Focusing on the Challenges with Vaccine Delivery Systems

By Cambridge Healthtech Institute
A Two Day Event Focusing on the Challenges in Vaccine Development

By Bio-IT World
Conference Short Course on Knowledge-Based Systems in Bioinformatics

By Cambridge Healthtech Institute
Hear Strategies and Technologies to Advance Vaccine Development

By Fast Market Research, Inc.
Europe to Strengthen Its Position as the Single Largest Market for Animal Vaccines Due To Highly Organized Livestock Farms

By Carol Adler, President, Dandelion Books, LLC
Vaccine Alert - New book from author, activist & Vaccination Liberation founder Wallene James – “The Vaccine Religion is a 21st Century Mass Mind Virus”

By Jennifer Stella
Nicole and Justin Matten of Barton, VT lost their 7 yr old daughter last December just 92 hrs after she received a flu shot. They recently joined the Vermont Coalition for Vaccine Choice to oppose proposed bills that threaten parental rights.

By Chloe Hibbert
2011 was an exciting time for the medical industry, with thousands of scientific breakthroughs bringing hope to patients and health experts across the world. ActiveQuote give you their top 10 weird and wonderful medical developments of last year.

By Helmut Landenberger
Modified strain of yeast paves way for new industrial vaccine production process

By GTC Conference
Vincent G. Brichard, SVP at GlaxoSmithKline to speak at Immunotherapeutics Partnering conference Jan 2012, San Diego, CA

By Joe Walsh
Piribo, the online destination for Pharma intelligence, has added a new report.

By ThinkMarketing
Scientists from The University of Edinburgh created a vaccine for Malaria, which has now been further developed after a study revealed a fundamental protein in the blood of African children...

By Netscribes
Netscribes (India) Pvt. Ltd., launches its Syringes & Needles Market in India Report 2011 covering one of the emerging markets in India with strong growth prospects . It is a part of Netscribes’ Healthcare Series reports.

By Insight Pharma Reports
New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

By Dan Aronovic
BiondVax Announces Receipt of IRB Ethics (“Helsinki”) Committee Approvals for the Initiation of Second Phase II Clinical Trial for Universal Influenza Vaccine. The trial will start in October 2011 with 120 participants over the age of 65.

By Shushmul Maheshwari
The biotech market in South Korea is forecasted to grow at a CAGR of around 35% during 2010-2013, says RNCOS in its latest research study.

By Dr Abubakar Yaro
This exciting event will bring together some of the leading TB researchers in the world to discuss the latest development in TB therapy.

By Hudson Valley Hospital Center
Hospital gearing up to make sure employees get flu shots

By RNCOS E-Services Pvt. Ltd.
The South Korean biotech industry is expected to grow at a CAGR of around 35% during 2010-2013, thereby contributing majorly to the Asia Pacific biotech market, says RNCOS in its latest research.

By Owner
The Best Veterinarian Care For Your Pets!

By Kalorama Information
Asthma is one of many diseases which may see a vaccine product within this decade, according to healthcare market research firm Kalorama Information's report What’s Next in Vaccines?

By Sheela Panicker
ROTAVAC® expecting India licensure during 2014 will be sold to global public markets at a price of US $ 1.0

By Shushmul Maheshwari
The Asia Pacific biotech market is expected to grow at a CAGR of around 19% during 2010-2013 on the back of demographic factors and increasing investments in the industry, says RNCOS.

By Danny Aronovic, Shapira Marketing
BiondVax Pharmaceuticals Ltd. is pleased to announce that the company's Chief Scientific Officer, Dr. Tamar Ben-Yedidia, will present the results of the Phase IIa clinical trial on the universal flu vaccine at the 2011 BIO International Convention.

By Kalorama Information
There is a significant amount of vaccine clinical trials going on in Asia, according to healthcare market research publisher Kalorama Information's research report Asian Vaccine Markets.

By Fast Market Research
Recently published research from Datamonitor, "Sanofi-Aventis: PharmaVitae Profile", is now available at Fast Market Research

By WoahMedia.com
New evidence suggests vaccinated children and adults suffer from significantly more ADHD, neurologic disorders, autism, asthma, allergies, respiratory infections and many other potentially serious illnesses, including cancer.

By Cambridge Healthtech Institute
Today, Inovio Pharmaceuticals reports long-term immune responses from therapeutic cervical dysplasia and cancer DNA vaccine. Mark Bagarazzi, M.D., Chief Medical Officer, will speak at CHI's Clinical Development of Vaccines conference.

By Cambridge Healthtech Institute
Vaccine leaders to convene at four co-located conferences on August 16-18, 2011 in Cambridge, Mass.

By Fast Market Research
New Healthcare research report from Business Monitor International is now available from Fast Market Research

By Fast Market Research
Recently published research from Business Monitor International, "Saudi Arabia Pharmaceuticals & Healthcare Report Q2 2011", is now available at Fast Market Research

By Organization of Teratology Information Specialists
OTIS Joins The Effort To Raise Awareness Of Meningitis Prevention

By Fast Market Research
Fast Market Research recommends "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

By Fast Market Research
New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

By Fast Market Research
New Healthcare market report from GlobalData: "Hester Biosciences Limited (524669) - Financial and Strategic Analysis Review"

By Fast Market Research
New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

By Fast Market Research
New Pharmaceuticals market report from Datamonitor: "Pipeline and Commercial Insight: Pneumococcal and Meningococcal Vaccines"

By Fast Market Research
New Healthcare research report from Business Monitor International is now available from Fast Market Research

By Jonathan Joel
Regulatory Officials recently made huge advances in Artificial Immune Function Technology Transitions for Assessing Vaccine and Biothreats Efficacy; whereby Knight Officials considered the legislative impact.

By Fast Market Research
New Pharmaceuticals market report from GlobalData: "Hepatitis B Vaccines - Pipeline Assessment and Market Forecasts to 2017"

By Danny Aronovic
BiondVax Pharmaceuticals Ltd., an Israeli biopharmaceutical company developing a Universal Influenza Vaccine, today announced that it has raised $1.25 million under its Standby Equity Distribution Agreement (SEDA) with YA Global Investments L.P.

By Danny Aronovic
Dr. Tamar Ben-Yedidia will be presenting at the Influenza Congress USA next week in Washington, D.C. BiondVax is currently in Phase IIa clinical trials (human subjects) for its Universal Influenza Vaccine.

By Miles for Hope
Miles For Hope, a Clearwater charity, will be the recipient of proceeds from a fundraising challenge set to raise critically needed awareness and funding of brain tumors

By Kalorama Information
Breast cancer accounts for approximately 12% of all cancers worldwide. In the U.S. more than 200,000 people develop breast cancer each year, with more than 95% of these women.

By Bharatbook
Bharatbook added a new report on "Global Vaccine Market Forecast to 2012" which gives extensive research and objective analysis of the vaccine market in key countries of the world. By RNCOS.




Page updated every 10 minutes


  1. SiteMap
  2. Contact PRLog
  3. Privacy Policy
  4. Terms of Service
  5. Copyright Notice
  6. About
  7. Advertise
Like PRLog?
9K2K1K
Click to Share